Alignment Healthcare (NASDAQ:ALHC) Insider Hyong Kim Sells 18,404 Shares

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Hyong Kim sold 18,404 shares of the company’s stock in a transaction that occurred on Wednesday, March 18th. The stock was sold at an average price of $17.84, for a total value of $328,327.36. Following the completion of the sale, the insider owned 367,701 shares in the company, valued at $6,559,785.84. The trade was a 4.77% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Hyong Kim also recently made the following trade(s):

• On Tuesday, January 6th, Hyong Kim sold 16,506 shares of Alignment Healthcare stock. The shares were sold at an average price of $21.35, for a total value of $352,403.10.
• On Monday, December 29th, Hyong Kim sold 12,694 shares of Alignment Healthcare stock. The shares were sold at an average price of $18.74, for a total value of $237,885.56.

Alignment Healthcare Trading Down 0.2%

NASDAQ ALHC opened at $18.16 on Friday. Alignment Healthcare, Inc. has a 12 month low of $11.63 and a 12 month high of $23.87. The stock has a market cap of $3.71 billion, a P/E ratio of -1,814.19, a P/E/G ratio of 2.66 and a beta of 1.18. The stock’s fifty day moving average price is $20.51 and its 200-day moving average price is $18.78. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.80.

Alignment Healthcare (NASDAQ:ALHC) last posted its quarterly earnings results on Thursday, February 26th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.15) by $0.10. The firm had revenue of $1.01 billion during the quarter, compared to analyst estimates of $1 billion. Alignment Healthcare had a negative return on equity of 0.49% and a negative net margin of 0.02%.Alignment Healthcare’s quarterly revenue was up 44.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.16) EPS. As a group, equities analysts forecast that Alignment Healthcare, Inc. will post -0.69 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the stock. UBS Group raised their price target on shares of Alignment Healthcare from $18.00 to $21.00 and gave the company a “neutral” rating in a research report on Wednesday, January 14th. Robert W. Baird set a $28.00 target price on Alignment Healthcare in a research note on Friday, January 30th. KeyCorp reissued an “overweight” rating and issued a $28.00 target price on shares of Alignment Healthcare in a report on Thursday, January 22nd. JPMorgan Chase & Co. boosted their price target on Alignment Healthcare from $23.00 to $26.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. Finally, TD Cowen upped their price target on Alignment Healthcare from $18.50 to $25.00 and gave the company a “buy” rating in a report on Friday, January 16th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $24.56.

Key Alignment Healthcare News

Here are the key news stories impacting Alignment Healthcare this week:

• Positive Sentiment: Analyst optimism — several brokerages have raised price targets and maintained Overweight/Buy views (Piper Sandler, KeyCorp, JPMorgan, Robert W. Baird), supporting upside expectations and a consensus “Moderate Buy” rating. MarketBeat ALHC Analyst Coverage
• Positive Sentiment: Recent earnings beat — Alignment reported Q4 revenue of ~$1.01B and EPS of ($0.05), topping consensus (revenue ~ $1.00B; EPS -$0.15), showing strong revenue growth (Y/Y +44%). This fundamental print remains supportive. Earnings Summary
• Neutral Sentiment: Zacks comparison piece — a valuation/comparison article contrasts ALHC with BrightSpring (BTSG); useful context for long-term investors but not an immediate market catalyst. BTSG or ALHC: Which Is the Better Value Stock Right Now?
• Neutral Sentiment: Reported short-interest data appears erroneous (shows 0 shares / NaN changes). Do not treat published short-interest figures as evidence of rising short pressure until exchanges correct the data.
• Negative Sentiment: CEO sale — John E. Kao sold 73,046 shares at an average $17.84 (~$1.30M), trimming his stake ~3.93%. This large insider sale is a near-term negative signal for sentiment. SEC Filing — Kao
• Negative Sentiment: Multiple senior insider sales on Mar 18 — President Dawn C. Maroney (36,749 shares, $17.84; also several prior sales in March/Jan), COO Sebastian Burzacchi (15,361 shares, $17.84), Christopher J. Joyce (25,125 shares, $17.84), Hyong Kim (18,404 shares, $17.84), Andreas P. Wagner (12,000 @ $17.84 and 11,602 @ $18.22), and Robert L. Scavo (11,285 shares, $17.84). These clustered disposals by senior management create headline risk and downward pressure. Representative filings: Maroney — Maroney SEC Filing; Joyce — Joyce SEC Filing; Wagner filings — Wagner SEC Filing

Institutional Investors Weigh In On Alignment Healthcare

Hedge funds have recently added to or reduced their stakes in the stock. Summit Securities Group LLC bought a new position in shares of Alignment Healthcare during the 4th quarter valued at $26,000. Parallel Advisors LLC grew its holdings in shares of Alignment Healthcare by 87.7% in the fourth quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock worth $33,000 after acquiring an additional 773 shares during the period. Larson Financial Group LLC purchased a new stake in Alignment Healthcare during the third quarter valued at $33,000. First Horizon Corp purchased a new stake in Alignment Healthcare during the fourth quarter valued at $39,000. Finally, SBI Securities Co. Ltd. lifted its holdings in Alignment Healthcare by 4,868.9% in the second quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company’s stock valued at $42,000 after acquiring an additional 2,970 shares during the period. 86.19% of the stock is currently owned by hedge funds and other institutional investors.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.